Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

What key factors are powering the surge in the myomectomy market right now?

The market for myomectomy has experienced substantial growth in the past few years. The market is expected to increase from $1.5 billion in 2024 to $1.62 billion in 2025 with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the historic period include rising incidences of uterine fibroids, advancements in surgical technologies, elevated awareness regarding treatment alternatives, increased patient demand for effective treatments, and enhancements in the healthcare infrastructure.

How fast Is the myomectomy market expected to grow, and what’s its future value?

In the coming years, the myomectomy market size will witness robust expansion, increasing to $2.23 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This projected growth during the prediction period stems from various factors including an increase in women opting for fertility-preserving therapies, improved access to specialized gynecological services, higher investment in innovative healthcare technology, an increasing occurrence of uterine disorders, and advanced surgical interventions’ healthcare expenditure surge. In the forecast period, major trends encompass minimally invasive and robotic-assisted surgeries, the incorporation of artificial intelligence into surgical planning, the creation of genetically-profiled personalized treatment schemes, advancements in non-invasive diagnostic apparatus, a surge in patient demand for fertility-preserving options, expanding worldwide access to sophisticated surgical technologies, emphasis on patient-centered healthcare and enhancements in postoperative recovery.

Get your myomectomy market report here!

https://www.thebusinessresearchcompany.com/report/myomectomy-global-market-report

What are the leading drivers of growth in the myomectomy market?

The myomectomy market’s growth is expected to be driven mainly by the increasing incidence of uterine disorders. These disorders encompass a wide range of ailments affecting the uterus, such as fibroids, endometriosis, and uterine cancer, resulting in various symptoms like pain, abnormal bleeding, and infertility. The rising incidence of these disorders can be linked to increased awareness, delayed childbearing, hormonal imbalances, and lifestyle changes. Myomectomy, a procedure to surgically remove fibroids, is employed to relieve symptoms such as pain, profuse bleeding, and reproductive issues while conserving the uterus. As an illustration, in January 2024, Cancer Australia, a cancer control agency based in Australia, reported that uterine cancer accounted for 561 deaths in Australia in 2020, and the projections for 2022 show a projected increase to 667 deaths. Thus, the escalation in uterine disorders’ prevalence is furthering the growth of the myomectomy market. A significant driver contributing to the myomectomy device market expansion is the escalating demand for minimally invasive techniques. Minimally invasive surgeries employ small incisions or natural body openings to assess and treat internal structures, organs, or tissues, thereby minimizing patient trauma. Due to their medical, financial, and aesthetic benefits, minimally invasive techniques are becoming increasingly popular among patients and healthcare providers across various medical disciplines. Occlusion devices, instrumental in minimally invasive procedures, are used to obstruct or seal blood vessels, ducts, or other routes within the body. These devices are commonly used in interventional cardiology, radiology, and other disciplines to address conditions like aneurysms, abnormal blood flow, or congenital heart defects. As an example, in January 2023, Intuitive Surgical Inc., a US-based tech corporation specializing in minimally invasive care products, revealed that around 1,875,000 surgical procedures were performed with Vinci surgical systems in 2022. This figure marks an approximate 18% increase from around 1,594,000 surgical procedures carried out in 2021. Thus, the burgeoning demand for minimally invasive techniques stimulates the progress of the myomectomy devices market.

What are the key segments defining the myomectomy market?

The myomectomy market covered in this report is segmented –

1) By Type: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy

2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products

3) By End-User: Hospitals And Clinics, Surgical Centers, Medical Device Companies, Other End-Users

Subsegments:

1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy

2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques

3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20576&type=smp

Who are the key players steering the development of the myomectomy market?

Major companies operating in the myomectomy market are AbbVie Inc., Medtronic plc, Stryker Corporation, Mayo Clinic, Boston Scientific Corporation, Johnson Hopkins Medicines, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., Columbia University Irving Medical Center, CooperSurgical Inc., Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Richard Wolf GmbH, Park Hospital, Phoenix Medical Devices, ERBE Elektromedizin GmbH, Advin Health Care, Sterling Surgicals, LiNA Medical ApS

What emerging trends are influencing the growth of the myomectomy market?

Prominent businesses involved in the myomectomy market are directing their attention towards the development of modern gynecologic procedures like the tissue extraction system in order to enhance surgical results and offer less invasive options for patients undertaking myomectomy. The Tissue Extraction System is a medical tool designed to support the extraction of large tissue samples during less invasive gynecologic surgeries, inclusive of myomectomy. For example, in November 2022, Olympus Corporation, a Japan-based manufacturer known for optics and reprography products, announced the introduction of the New Gynecologic Power Morcellator. This Morcellation Morcellator, which forms part of the Olympus-contained tissue extraction system, is specifically formulated for complex gynecologic procedures that require dealing with large, calcified tissue samples. When coupled with the PneumoLiner containment instrument, it offers selected patients a less invasive alternative to traditional hysterectomy or myomectomy.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20576

Which regions are most influential in expanding the myomectomy market?

North America was the largest region in the myomectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Surgical Stapling Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surgical-stapling-products-global-market-report

Surgical Stapling Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surgical-stapling-devices-global-market-report

Powered Surgical Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/powered-surgical-instruments-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: